The summary below is from the full report titled “Should All Patients with Type 1 Diabetes Mellitus and Microalbuminuria Receive Angiotensin-Converting Enzyme Inhibitors? A Meta-Analysis of Individual Patient Data.” It is in the 6 March 2001 issue of Annals of Internal Medicine (volume 134, pages 370-379). The author is the ACE Inhibitors in Diabetic Nephropathy Trialist Group.
The Effect of ACE Inhibitors on Kidney Function in Patients with Type 1 Diabetes. Ann Intern Med. 2001;134:I–86. doi: https://doi.org/10.7326/0003-4819-134-5-200103060-00005
Download citation file:
Published: Ann Intern Med. 2001;134(5):I-86.
Cardiology, Coronary Risk Factors, Diabetes, Endocrine and Metabolism, Hypertension.
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use